Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment.

被引：0
|
作者：
Akce, Mehmet
El-Khoueiry, Anthony B.
Piha-Paul, Sarina Anne
Bacque, Emeline
Pan, Peng
Zhang, Zhi-Yi
Ewesuedo, Reginald
Gupta, Divya
Milton, Ashley
Judson, Patricia
O'Bryant, Cindy L.
机构：
[1] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Univ Southern Calif, Norris Comprehens Canc Ctr, Newport Beach, CA USA
[3] Univ Southern Calif, Hoag Mem Hosp, Presbyterian Canc Ctr, Newport Beach, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA
[5] GlaxoSmithKline, Waltham, MA USA
[6] Univ Colorado, Canc Ctr, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6054
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment
    Moton, Allen
    Krishna, Gopal
    Ma, Lei
    O'Mara, Edward
    Prasad, Pratapa
    McLeod, James
    Preston, Richard A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (01) : 1 - 7
  • [32] Mild to Moderate Hepatic Impairment Has No Effect on the Single Dose Pharmacokinetics of Alisporivir (ALV)
    Kovacs, Steven J.
    Ke, June
    Praestgaard, Jens
    Barve, Avantika
    Zhang, Jie
    Maietta, Robert
    Sunkara, Gangadhar
    Stein, Daniel S.
    GASTROENTEROLOGY, 2013, 144 (05) : S977 - S977
  • [33] Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
    Magda S. C. Fontes
    Jasper Dingemanse
    Atef Halabi
    Monika Tomaszewska-Kiecana
    Patricia N. Sidharta
    Scientific Reports, 12
  • [34] Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment
    Marshall, William L.
    Feng, Hwa-Ping
    Wenning, Larissa
    Garrett, Graigory
    Huang, Xiaobi
    Liu, Fang
    Panebianco, Deborah
    Caro, Luzelena
    Fandozzi, Christine
    Lasseter, Kenneth C.
    Preston, Richard A.
    Marbury, Thomas
    Butterton, Joan R.
    Iwamoto, Marian
    Yeh, Wendy W.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (03) : 321 - 329
  • [35] Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
    Fontes, Magda S. C.
    Dingemanse, Jasper
    Halabi, Atef
    Tomaszewska-Kiecana, Monika
    Sidharta, Patricia N.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Hepatic impairment does not alter the single-dose pharmacokinetics and safety of entecavir
    Bifano, M
    Yan, JH
    Xie, J
    Zhang, D
    Freund, J
    Grasela, D
    LaCreta, F
    ANTIVIRAL THERAPY, 2004, 9 (06) : H23 - H24
  • [37] Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment
    William L. Marshall
    Hwa-Ping Feng
    Larissa Wenning
    Graigory Garrett
    Xiaobi Huang
    Fang Liu
    Deborah Panebianco
    Luzelena Caro
    Christine Fandozzi
    Kenneth C. Lasseter
    Richard A. Preston
    Thomas Marbury
    Joan R. Butterton
    Marian Iwamoto
    Wendy W. Yeh
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 321 - 329
  • [38] Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment
    Yukio Shimasaki
    Masashi Sakaki
    Minoru Itou
    Tokurou Kobayashi
    Masako Aso
    Tomoya Kagawa
    Takuya Saiki
    Kumi Matsuno
    Yuhei Sano
    Kohei Shimizu
    Shingo Kuroda
    Emiko Koumura
    Clinical Drug Investigation, 2018, 38 : 1041 - 1051
  • [39] Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment
    Shimasaki, Yukio
    Sakaki, Masashi
    Itou, Minoru
    Kobayashi, Tokurou
    Aso, Masako
    Kagawa, Tomoya
    Saiki, Takuya
    Matsuno, Kumi
    Sano, Yuhei
    Shimizu, Kohei
    Kuroda, Shingo
    Koumura, Emiko
    CLINICAL DRUG INVESTIGATION, 2018, 38 (11) : 1041 - 1051
  • [40] Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment
    Schaad, HJ
    Petty, BG
    Grasela, DM
    Christofalo, B
    Raymond, R
    Stewart, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) : 2793 - 2796
12345